- Home
- VTYX vs ISPR Comparison
VTYX vs ISPR Comparison
Compare VTYX & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- ISPR
- Stock Information
- Founded
- VTYX 2018
- ISPR 2019
- Country
- VTYX United States
- ISPR United States
- Employees
- VTYX N/A
- ISPR N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- ISPR Medicinal Chemicals and Botanical Products
- Sector
- VTYX Health Care
- ISPR Health Care
- Exchange
- VTYX Nasdaq
- ISPR Nasdaq
- Market Cap
- VTYX 154.9M
- ISPR 152.0M
- IPO Year
- VTYX 2021
- ISPR 2023
- Fundamental
- Price
- VTYX $2.79
- ISPR $2.92
- Analyst Decision
- VTYX Buy
- ISPR Strong Buy
- Analyst Count
- VTYX 4
- ISPR 2
- Target Price
- VTYX $11.33
- ISPR $10.00
- AVG Volume (30 Days)
- VTYX 2.0M
- ISPR 100.1K
- Earning Date
- VTYX 08-07-2025
- ISPR 09-10-2025
- Dividend Yield
- VTYX N/A
- ISPR N/A
- EPS Growth
- VTYX N/A
- ISPR N/A
- EPS
- VTYX N/A
- ISPR N/A
- Revenue
- VTYX N/A
- ISPR $144,700,345.00
- Revenue This Year
- VTYX N/A
- ISPR N/A
- Revenue Next Year
- VTYX N/A
- ISPR $35.39
- P/E Ratio
- VTYX N/A
- ISPR N/A
- Revenue Growth
- VTYX N/A
- ISPR N/A
- 52 Week Low
- VTYX $0.78
- ISPR $2.09
- 52 Week High
- VTYX $3.39
- ISPR $7.93
- Technical
- Relative Strength Index (RSI)
- VTYX 62.76
- ISPR 56.89
- Support Level
- VTYX $1.95
- ISPR $2.65
- Resistance Level
- VTYX $2.51
- ISPR $3.00
- Average True Range (ATR)
- VTYX 0.17
- ISPR 0.31
- MACD
- VTYX -0.02
- ISPR 0.06
- Stochastic Oscillator
- VTYX 104.37
- ISPR 73.28
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.